Get started
Keyword

levodopa

Description: A dopamine precursor medication used primarily to treat the motor symptoms of Parkinson’s disease and other disorders involving dopamine deficiency.
Wikidata ID: wiki/Q300989
OpenAlex ID: keywords/levodopa
Diagnosis and management of dementia with Lewy bodies
2005 · I. G. McKeith, D. W. Dickson, et al. · Neurology · 5,109
Parkinson's disease
2021 · Bastiaan R Bloem, Michael S Okun, et al. · The Lancet · 3,865
PDF
Diagnosis and Treatment of Parkinson Disease
2020 · Melissa J. Armstrong, Michael S. Okun · JAMA · 2,895
Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations
1973 · H. Bernheimer, W. Birkmayer, et al. · Journal of the Neurological Sciences · 2,651
Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease
2001 · Curt R. Freed, Paul E. Greene, et al. · New England Journal of Medicine · 2,367
PDF
Levodopa and the Progression of Parkinson's Disease
2004 · The Parkinson Study Group · New England Journal of Medicine · 1,840
PDF
A Five-Year Study of the Incidence of Dyskinesia in Patients with Early Parkinson's Disease Who Were Treated with Ropinirole or Levodopa
2000 · Olivier Rascol, David J. Brooks, et al. · New England Journal of Medicine · 1,544
PDF
Pharmacological Treatment of Parkinson Disease
2014 · Barbara S. Connolly, Anthony E. Lang · JAMA · 1,499
Impulse Control Disorders in Parkinson Disease
2010 · Daniel Weintraub, Juergen Koester, et al. · Archives of Neurology · 1,487
Etiology and Pathogenesis of Parkinson's Disease
1999 · C. W. Olanow, W. G. Tatton · Annual Review of Neuroscience · 1,396
Dopamine Dependency of Oscillations between Subthalamic Nucleus and Pallidum in Parkinson's Disease
2001 · Peter Brown, Antonio Oliviero, et al. · Journal of Neuroscience · 1,174
Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia
1994 · Jeswinder Sian, David T. Dexter, et al. · Annals of Neurology · 1,160
Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action
1999 · Søren H. Sindrup, Troels S. Jensen · Pain · 1,144
Sydney multicenter study of Parkinson's disease: Non‐ L ‐dopa–responsive problems dominate at 15 years
2004 · Mariese A. Hely, John G.L. Morris, et al. · Movement Disorders · 1,050
Deep brain stimulation for Parkinson’s disease
2003 · Alim Louis Benabid · Current Opinion in Neurobiology · 1,046
International Parkinson and movement disorder society evidence‐based medicine review: Update on treatments for the motor symptoms of Parkinson's disease
2018 · Susan H. Fox, Regina Katzenschlager, et al. · Movement Disorders · 1,003
Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease
2001 · Rachel Reed, P Aul E. G Reene, et al. · 1,001
The scientific and clinical basis for the treatment of Parkinson disease (2009)
2009 · C. Warren Olanow, Matthew B. Stern, et al. · Neurology · 910
Reduction in subthalamic 8–35 Hz oscillatory activity correlates with clinical improvement in Parkinson's disease
2006 · Andrea A. Kühn, Andreas Kupsch, et al. · European Journal of Neuroscience · 893
‘frontal’ Cognitive Function in Patients With Parkinson's Disease ‘on’and ‘off’ Levodopa
1988 · A.M. GOTHAM, R.G. BROWN, et al. · Brain · 835
Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET study
2003 · Alan L. Whone, Ray L. Watts, et al. · Annals of Neurology · 829
Pramipexole vs Levodopa as initial treatment for Parkinson disease: A randomized controlled trial
2000 · Robert G. Holloway, Ira Shoulson, et al. · JAMA · 800
Manganese toxicity upon overexposure
2004 · Janelle Crossgrove, Wei Zheng · NMR in Biomedicine · 799
Pramipexole vs Levodopa as Initial Treatment for Parkinson Disease
2000 · Parkinson Study Group · JAMA · 767
Tolcapone
1998 · Stanley Fahn · Neurology · 736
Works count: 15,080
Citation count: 359,300
Year
Topic
Type